Optical imaging to predict full response to breast cancer chemo
Part of Cancer clinical trials.
This study uses a light-based scanner (optical imaging) during neoadjuvant chemotherapy to see how your breast cancer responds and to predict whether treatment will fully clear the tumor. If you qualify, it may help researchers better match imaging patterns to treatment success.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a woman age 18 or older
- Have a new (recent) breast cancer diagnosis and plan to start neoadjuvant chemotherapy (chemo before surgery)
- Be willing and able to sign informed consent
- Not be pregnant or breastfeeding during the study
- No prior surgery on the same breast
- No distant metastasis (cancer that has spread to other organs)
- No breast implants
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study looks at how well early breast cancer shrinks with treatment and how that matches with what doctors find after surgery under the microscope. The goal is to learn better ways to predict and assess treatment success.
This study uses a special type of mammogram with contrast dye to see if it can predict how well breast cancer responds to chemotherapy before surgery. It's for people with HER2-positive or triple-negative breast cancer.
This study uses ultrasound and/or MRI scans to see how breast cancer responds early while you start “neoadjuvant” treatment (chemotherapy, with or without radiation before surgery). It may help doctors spot response sooner and better understand which imaging changes match treatment benefit.
This study uses a special light-based device to monitor breast cancer during chemotherapy before surgery. It is for women with HER2-positive or triple-negative breast cancer who are planning chemotherapy first.
This study uses a special light-based imaging scan to learn more about breast masses and how tumors may respond to chemotherapy before surgery. The scan is meant to help doctors better characterize tumors and potentially track treatment response.
This study uses special PET/MRI scans to see how well breast cancer treatments are working. It aims to find better ways to monitor your cancer and guide your care.
Hear when a new Breast Cancer Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.